The short answer on cost
A tiered RUO peptide product liability program places businesses in one of four limit and deductible structures. Base premiums start at $7,500 for $100,000 per claim / $200,000 aggregate limits with a $5,000 deductible, and rise through $15,000 for $200,000 / $400,000, $37,500 for $500,000 / $500,000, and $75,000 for $1,000,000 per claim / $2,000,000 aggregate.
Those are base premiums, not quotes. Final pricing depends on revenue, units shipped, product mix, distribution channels, and documentation. Every figure below is indicative and subject to underwriting.
Why the range is so wide
Product liability for ingestible and injectable-adjacent products is severity-driven, not frequency-driven. One claim can exceed a small seller's annual revenue, so carriers price the tail rather than the average. Four factors do most of the work:
1. Revenue and units shipped
Exposure scales with how much product reaches the market, not with headcount. A three-person operation shipping thousands of vials carries more exposure than a ten-person business selling research quantities to laboratories.
2. Manufacturer versus reseller
Making the product carries more exposure than distributing it. A contract manufacturer arrangement adds a layer of contractual liability that a pure reseller never touches, and carriers ask which role you actually play before they price.
3. Product mix
Lyophilized research compounds, injectable-adjacent products, and GLP-1 related offerings price differently from one another. The presence of any product intended for human use changes the conversation entirely, and some carriers will not write it at all.
4. Documentation
Certificates of analysis, batch records, third-party testing, and consistent labeling are the difference between a decline and a quote. This is the factor a seller controls most directly, and the one that most often stalls an application.
What a deductible change does
The published tiers all sit at a $5,000 deductible. Moving to a higher deductible lowers premium but shifts the first loss onto the business, which only makes sense if the cash is genuinely available. In this class, a business that cannot fund its deductible tends to make claim decisions based on cash flow rather than on the merits, which is a worse outcome than paying more premium.
How to prepare before requesting a quote
- Certificates of analysis for each product, from an accredited laboratory
- Label artwork showing the research use only statement
- The website and checkout flow, including any buyer verification step
- A product list with revenue and unit concentration
- Prior claims, recalls, chargebacks, and any regulatory contact
- Whether you manufacture, repackage, or resell
Accounts that arrive with this package move through underwriting faster and usually land closer to the base premium than accounts that arrive with a revenue figure and a website link.
Where sellers get surprised
Two things show up repeatedly. First, merchant processors and suppliers ask for a certificate before they will open an account, so coverage is often a revenue prerequisite rather than a risk decision. Second, an RUO label on the vial paired with a website that implies human use creates a documented inconsistency that carriers treat as a coverage problem, not a marketing one.
Next step
The full tier structure, coverage details, and underwriting checklist live on the RUO peptide insurance hub. To price your own operation, request a peptide quote and include your product list and revenue.
This article is general information, not a quote or an offer of coverage. Premiums and terms are set by the carrier after underwriting review.